Mail

OMCL - Omnicell, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

66.51

-0.01 (-0.02%)

As of 11:54AM EST. Market open.

Stock chart is not supported by your current browser

Previous Close	66.52
Open	66.75
Bid	66.56 x 800
Ask	66.68 x 800
Day's Range	65.65 - 67.24
52 Week Range	39.75 - 79.48
Volume	60,719
Avg. Volume	368,682

Market Cap	2.636B
Beta (3Y Monthly)	1.65
PE Ratio (TTM)	61.58
EPS (TTM)	1.08
Earnings Date	Jan 30, 2019 - Feb 4, 2019
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	73.38

Trade prices are not sourced from all markets

All

News

Press Releases

Zacks2 days ago
Why You Should Consider Buying Omnicell (OMCL) Stock Now
Omnicell (OMCL) is pulling out all the stops to strengthen the medication adherence segment.
Simply Wall St.7 days ago
What Does Omnicell, Inc.’s (NASDAQ:OMCL) Share Price Indicate?
Omnicell, Inc. (NASDAQ:OMCL), which is in the healthcare services business, and is based in United States, saw a double-digit share price rise of over 10% in the past couple of Read More...
Benzinga11 days ago
Pivotal Updates Ad Agencies Ahead of Q4 Earnings
Multiple ad agencies are facing concerns mostly due to the disruptions their core customers face. But at today's valuations, most ad stocks are fully pricing in concerns, according to Pivotal Research ...
Zacks14 days ago
Omnicell (OMCL) Rides on Innovation Despite Cost Concerns
Omnicell (OMCL) steadily sees a solid uptake of Omnicell XT. It also strikes various deals for the XR2 and IVX Workflow products.
PR Newswire22 days ago
Omnicell To Present At The 37th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif. , Dec. 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, ...
Zackslast month
Allscripts Healthcare (MDRX) Catches Eye: Stock Jumps 5.7%
Allscripts Healthcare (MDRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
PR Newswirelast month
Northeast Georgia Health System Selects Omnicell Automated Medication Management Platform to Support Newly Redesigned Pharmacy
Automated solutions help enhance quality and safety for medication management and in-house sterile compounding MOUNTAIN VIEW, Calif. , Dec. 5, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced ...
Simply Wall St.last month
Does Omnicell Inc’s (NASDAQ:OMCL) CEO Salary Compare Well With Others?
Randy Lipps became the CEO of Omnicell Inc (NASDAQ:OMCL) in 2002. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we’ll look Read More...
Zacks2 months ago
Here's Why You Should Invest in Omnicell (OMCL) Stock Now
Omnicell (OMCL) continues to witness strong conversion wins for new XT series.
PR Newswire2 months ago
Omnicell Launches Vision for Fully Digitized, Autonomous Pharmacy at Annual ASHP Midyear Meeting
MOUNTAIN VIEW, Calif., Dec. 3, 2018 /PRNewswire/ -- Omnicell, Inc., (OMCL) a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, announced the Company will be showcasing the industry's most comprehensive and customizable platform of medication management automation solutions at this year's American Society of Health-System Pharmacists 2018 Midyear Meeting, to be held in Anaheim, CA from December 2-6. "Radical change in pharmacy care delivery is needed to improve the system," said Randall A. Lipps, chairman, president, chief executive officer, and founder of Omnicell.
PR Newswire2 months ago
Omnicell To Present At The 30th Annual Piper Jaffray Healthcare Conference
MOUNTAIN VIEW, Calif. , Nov. 14, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, ...
Zacks2 months ago
Omnicell (OMCL) Hits Fresh High: Is There Still Room to Run?
Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks2 months ago
US Stocks Enjoy Highest Post-Midterm Gains Since 1982: 5 Picks
A large swathe of market watchers thinks that a gridlocked Congress will be beneficial for U.S. equity markets.
Thomson Reuters StreetEvents2 months ago
Edited Transcript of OMCL earnings conference call or presentation 25-Oct-18 8:30pm GMT
Q3 2018 Omnicell Inc Earnings Call
Zacks3 months ago
Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q3
Omnicell's (OMCL) third-quarter 2018 performance impresses with year-over-year growth in earnings and revenues.
Zacks3 months ago
Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates
Omnicell (OMCL) delivered earnings and revenue surprises of 12.50% and 0.39%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Associated Press3 months ago
Omnicell: 3Q Earnings Snapshot
On a per-share basis, the Mountain View, California-based company said it had net income of 33 cents. Earnings, adjusted for amortization costs and stock option expense, were 63 cents per share. The results ...
PR Newswire3 months ago
Omnicell Achieves Record Revenue in the Third Quarter 2018
GAAP revenues of $204 million , up 9.4% year-over-year GAAP net income per diluted share of $0.33 , up 65% year-over-year Non-GAAP revenues of $204 million , up 9.2% year-over-year Non-GAAP net income ...
PR Newswire3 months ago
Omnicell to Release Third Quarter 2018 Earnings Results on October 25, 2018
MOUNTAIN VIEW, Calif. , Oct. 18, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, ...
Zacks3 months ago
Omnicell (OMCL) Q3 Earnings Preview: What to Look Out For
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR Newswire3 months ago
Augusta University Health Selects Omnicell's Industry-Leading Medication Management Portfolio to Support Newly Redesigned Pharmacy
Solutions Leverage Automation to Help Optimize Hospital Workflows, Improve Financial Performance and Enhance Patient Safety MOUNTAIN VIEW, Calif. , Oct. 10, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: ...
PR Newswire4 months ago
Middlesex Hospital Bolsters Pharmacy Safety and Compliance by Extending Wolters Kluwer's Simplifi 797 with Omnicell's IVX Workflow
MOUNTAIN VIEW, Calif., Sept. 18, 2018 /PRNewswire/ -- Wolters Kluwer, Health and Omnicell, Inc. (OMCL) today announced that Connecticut-based Middlesex Hospital has extended its use of Simplifi 797® and has chosen Omnicell's IVX Workflow to automate the hospital's sterile compounding operations. The companies provide a turnkey solution that combines the expertise and best-practice approach of quality management solution Simplifi 797 with the advanced IVX Workflow technology from Omnicell. Scrutiny of compounding policies followed a high-profile meningitis outbreak in 2012 that brought to light weaknesses in the state-level oversight of these potentially risky drugs and the contamination-prone environments where they are formulated.
Zacks4 months ago
Omnicell Continues to Pursue Buyouts, Costs on the Rise
Omnicell (OMCL) progresses well with its strategy to grow inorganically. Rising operating expenses a concern.
PR Newswire4 months ago
Rob Seim to retire and join Omnicell Board of Directors
MOUNTAIN VIEW, Calif., Sept. 14, 2018 /PRNewswire/ -- Omnicell, Inc. (OMCL), the leading provider of medication and supply management technology across the continuum of care, today announced that Rob Seim, President of Global Automation and Medication Adherence, has indicated his intent to retire as of March 15, 2019. The company also announced the appointment of Mr. Seim to the Board of Directors following his retirement. Mr. Seim served Omnicell as its Chief Financial Officer for nearly 10 years and was also Executive Vice President of Finance, Administration, and Manufacturing during that time. For the past three years, Mr. Seim has served as President of Global Automation and Medication Adherence which includes responsibility for all of the non-US business of Omnicell, several product lines, and worldwide manufacturing. During his 13 years at Omnicell, revenue grew over 550% and market valuation grew over 8 fold.